Patología Molecular del Cáncer

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Schultheis AM, Ng CK, De Filippo MR, Piscuoglio S, Macedo GS, Gatius S, Perez Mies B, Soslow RA, Lim RS, Viale A, Huberman KH, Palacios JC, Reis-Filho JS, Matias-Guiu X, Weigelt B.

    Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.

    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE . 108(6): . Nº de citas: 107

    [doi:10.1093/jnci/djv427]

  • Hmadcha A, Aguilera Y, Lozano-Arana MD, Mellado N, Sánchez J, Moya C, Sánchez-Palazón L, Palacios J, Antiñolo G, Soria B.

    Derivation of HVR1, HVR2 and HVR3 human embryonic stem cell lines from IVF embryos after preimplantation genetic diagnosis (PGD) for monogenic disorder.

    STEM CELL RESEARCH . 16(3): 635-639. Nº de citas: 1

    [doi:10.1016/j.scr.2016.03.012]

  • Ferrer I, Verdugo-Sivianes EM, Castilla MA, Melendez R, Marin JJ, Muñoz-Galvan S, Lopez-Guerra JL, Vieites B, Ortiz-Gordillo MJ, De León JM, Praena-Fernandez JM, Perez M, Palacios J, Carnero A.

    Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors

    Oncogene . 35(21): 2777-2788. Nº de citas: 21

    [doi:10.1038/onc.2015.341]

  • Alba E, Lluch A, Ribelles N, Anton-Torres A, Sanchez-Rovira P, Albanell J, Calvo L, García-Asenjo JA, Palacios J, Chacon JI, Ruiz A, De la Haba-Rodriguez J, Segui-Palmer MA, Cirauqui B, Margeli M, Plazaola A, Barnadas A, Casas M, Caballero R, Carrasco E, Rojo F.

    High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.

    ONCOLOGIST . 21(2): 150-155. Nº de citas: 21

    [doi:10.1634/theoncologist.2015-0312]

  • Martínez-Iglesias OA, Alonso-Merino E, Gómez-Rey S, Velasco-Martín JP, Martín Orozco R, Luengo E, García Martín R, Ibáñez de Cáceres I, Fernández AF, Fraga MF, González-Peramato P, Varona C, Palacios J, Regadera J, Aranda A.

    Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis.

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA . 113(3): 328-337. Nº de citas: 29

    [doi:10.1073/pnas.1520469113]

  • Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, Calvo JP, Dabbs DJ, Ellis IO, Eusebi V, Farshid G, Fox SB, Ichihara S, Lakhani SR, Rakha EA, Reis-Filho JS, Richardson AL, Sahin A, Schmitt FC, Schnitt SJ, Siziopikou KP, Soares FA, Tse GM, Vincent-Salomon A, Tan PH.

    Phyllodes tumours of the breast: a consensus review.

    Histopathology . 68(1): 5-21. Nº de citas: 187

    [doi:10.1111/his.12876]

  • Rakha EA, Badve S, Eusebi V, Reis-Filho JS, Fox SB, Dabbs DJ, Decker T, Hodi Z, Ichihara S, Lee AH, Palacios J, Richardson AL, Vincent-Salomon A, Schmitt FC, Tan PH, Tse GM, Ellis IO.

    Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management

    Histopathology . 68(1): 45-56. Nº de citas: 20

    [doi:10.1111/his.12861]

  • Gayarre J, Kamieniak MM, Cazorla-Jiménez A, Muñoz-Repeto I, Borrego S, García-Donas J, Hernando S, Robles-Díaz L, García-Bueno JM, Cajal TR, Hernández-Agudo E, Soto VH, Márquez-Rodas I, Echarri MJ, Lacambra-Calvet C, Sáez R, Cusidó M, Redondo A, Paz-Ares L, Hardisson D, Mendiola M, Palacios J, Benítez J, García MJ.

    The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients

    JOURNAL OF GYNECOLOGIC ONCOLOGY . 27(1): . Nº de citas: 13

    [doi:10.3802/jgo.2016.27.e7]

  • Miguel-Gomez L, Turrion-Merino L, Reguero-Calleja ME, Muñoz-Zato E.

    Subungual Keratoacanthoma

    Indian journal of dermatology . 60(6): 623-624.

    [doi:10.4103/0019-5154.169148]

  • Romero-Pérez L, Garcia-Sanz P, Mota A, Leskelä S, Hergueta-Redondo M, Díaz-Martín J, López-García MA, Castilla MA, Martínez-Ramírez A, Soslow RA, Matias-Guiu X, Moreno-Bueno G, Palacios J.

    A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer

    MODERN PATHOLOGY . 28(11): 1492-1503. Nº de citas: 17

    [doi:10.1038/modpathol.2015.102]

  • Diaz-Martin, Juan, Angeles Lopez-Garcia, Maria, Romero-Perez, Laura, Reina Atienza-Amores, Maria, Luisa Pecero, Maria, Angeles Castilla, Maria, Biscuola, Michele, Santon, Almudena, Palacios, Jose.

    Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer

    ENDOCRINE-RELATED CANCER . 22(3): 443-454. Nº de citas: 48

    [doi:10.1530/ERC-14-0456]

  • Calvete O, Reyes J, Zuñiga S, Paumard-Hernández B, Fernández V, Bujanda L, Rodriguez-Pinilla MS, Palacios J, Heine-Suñer D, Banka S, Newman WG, Cañamero M, Pritchard DM, Benítez J.

    Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour

    HUMAN MOLECULAR GENETICS . 24(10): 2914-2922. Nº de citas: 48

    [doi:10.1093/hmg/ddv054]

  • Leskela S, Serrano A, de la Fuente H, Rodríguez-Muñoz A, Ramos-Levi A, Sampedro-Nuñez M, Sánchez-Madrid F, González-Amaro R, Marazuela M.

    Graves' Disease Is Associated with a Defective Expression of the Immune Regulatory Molecule Galectin-9 in Antigen-Presenting Dendritic Cells

    Plos One . 10(4): . Nº de citas: 13

    [doi:10.1371/journal.pone.0123938]

  • Alonso-Alconada L, Santacana M, Garcia-Sanz P, Muinelo-Romay L, Colas E, Mirantes C, Monge M, Cueva J, Oliva E, Soslow RA, Lopez MA, Palacios J, Prat J, Valls J, Krakstad C, Salvesen H, Gil-Moreno A, Lopez-Lopez R, Dolcet X, Moreno-Bueno G, Reventos J, Matias-Guiu X, Abal M.

    Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    INTERNATIONAL JOURNAL OF CANCER . 136(8): 1863-1873. Nº de citas: 29

    [doi:10.1002/ijc.29213]

  • Diaz-Lopez, Antonio, Diaz-Martin, Juan, Moreno-Bueno, Gema, Cuevas, Eva P., Santos, Vanesa, Olmeda, David, Portillo, Francisco, Palacios, Jose, Cano, Amparo.

    Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT

    INTERNATIONAL JOURNAL OF CANCER . 136(4): 62-73. Nº de citas: 48

    [doi:10.1002/ijc.29177]

  • Kamieniak MM, Rico D, Milne RL, Muñoz-Repeto I, Ibáñez K, Grillo MA, Domingo S, Borrego S, Cazorla A, García-Bueno JM, Hernando S, García-Donas J, Hernández-Agudo E, Y Cajal TR, Robles-Díaz L, Márquez-Rodas I, Cusidó M, Sáez R, Lacambra-Calvet C, Osorio A, Urioste M, Cigudosa JC, Paz-Ares L, Palacios J, Benítez J, García MJ.

    Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients

    MOLECULAR ONCOLOGY . 9(2): 422-436. Nº de citas: 13

    [doi:10.1016/j.molonc.2014.09.010]

  • López-Calderero I, Carnero A, Astudillo A, Palacios J, Chaves M, Benavent M, Limón ML, Garcia-Carbonero R.

    Prognostic relevance of estrogen receptor-alpha Ser167 phosphorylation in stage II-III colon cancer patients

    HUMAN PATHOLOGY . 45(12): 2437-2446. Nº de citas: 9

    [doi:10.1016/j.humpath.2014.08.008]

  • Santacana M, Maiques O, Valls J, Gatius S, Abó AI, López-García MÁ, Mota A, Reventós J, Moreno-Bueno G, Palacios J, Bartosch C, Dolcet X, Matias-Guiu X.

    A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

    HUMAN PATHOLOGY . 45(12): 2394-2403. Nº de citas: 10

    [doi:10.1016/j.humpath.2014.06.031]